MDxHealth is trading at $0.17, up 7.2%, alongside a broad market rally. - Major U.S. indices are up more than 1.7%; easing election uncertainty and stronger risk appetite may be supporting the move. - No new company-specific announcement was identified for November 4. The latest releases concern preliminary third-quarter results and suspended full-year guidance, announced October 15. - A results call is scheduled for November 12.